Finerenone Patent Expiration

Finerenone was first introduced by Bayer Healthcare Pharmaceuticals Inc in its drug Kerendia on Jul 9, 2021.

Finerenone Patents

Given below is the list of patents protecting Finerenone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Kerendia	USRE49826	Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredient	Jul 29, 2035	Bayer Hlthcare
Kerendia	US8436180	Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof	Apr 12, 2029	Bayer Hlthcare

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List